Hedgeye Quality Growth ETF (HGRO) seeks to provide exposure to high-quality growth companies using Hedgeye Risk Management's proprietary research methodology. This actively managed growth ETF targets companies with strong fundamentals, sustainable competitive advantages, and above-average earnings growth potential across various market capitalizations.
How It Works
HGRO employs an active management approach utilizing Hedgeye's quantitative and qualitative research framework to identify quality growth stocks. The fund's portfolio managers select companies based on proprietary scoring models that evaluate financial strength, earnings quality, management effectiveness, and growth sustainability. Holdings are concentrated in 30-50 positions with quarterly rebalancing based on fundamental analysis updates. The strategy emphasizes bottom-up stock selection rather than sector or market-cap constraints.
Key Features
- Leverages Hedgeye Risk Management's institutional research platform used by professional investors and hedge funds globally
- Concentrated portfolio of 30-50 high-conviction positions allows for meaningful impact from best investment ideas
- Zero expense ratio at launch provides significant cost advantage over typical actively managed growth funds charging 0.75-1.50%
Risks
- This ETF can lose value if the manager's stock selection proves incorrect, as concentrated holdings amplify individual company impacts on performance
- Growth stocks can decline 40-60% during market downturns as investors rotate to value stocks and defensive sectors
- Active management risk means the fund may underperform passive growth ETFs during periods when stock-picking adds little value
Who Should Own This
Best suited for growth-oriented investors with 3-7 year time horizons and high risk tolerance seeking active management exposure. Appropriate as a satellite holding representing 10-25% of equity allocation for investors comfortable with concentrated positions and manager risk. Appeals to those wanting institutional-quality research without hedge fund minimums.